Why the study?
Pulmonary embolism remains a common and potentially deadly disease despite advances in diagnostic imaging, treatment, and prevention, requiring a multifactorial approach to management.
Key points are not available for this paper at this time.
Design
Review
Provides synthesized guidance on probability-based PE strategies; leaves open need for updated prospective validation.
Pulmonary embolism remains a common and potentially deadly disease, despite advances in diagnostic imaging, treatment and prevention. Managing pulmonary embolism requires a multifactorial approach involving risk stratification, determining appropriate diagnostics and selecting individualised therapy. This article reviews the pathophysiology, risk factors, clinical presentation, diagnostic evaluation and therapeutic management and early outpatient management of pulmonary embolism. The second part summarises pulmonary embolism in the setting of pregnancy, COVID-19, recurrent disease and chronic thromboembolic pulmonary hypertension.
No takes yet. Share an insight, caveat, or question.
Stolberg et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: